VarCov Co’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,895
Closed -$257K – 528
2026
Q2
$257K Buy
+2,895
New +$211K 0.1% 305
2026
Q1
– Sell
-8,008
Closed -$262K – 621
2025
Q4
$262K Buy
+8,008
New +$209K 0.1% 327

Other funds holding SYRE

VarCov Co's SYRE Position: Q3 2026 in Review

VarCov Co sold out of Spyre Therapeutics (SYRE) in Q3 2026, closing a stake of 2,895 shares — an estimated $257K sold.

VarCov Co first reported a position in SYRE in Q4 2025 and held it in 2 quarters. The position peaked at $262K in Q4 2025. 286 funds tracked by Wall St. Rank hold SYRE as of Q3 2026.

  • VarCov Co reported no remaining Spyre Therapeutics position as of Q3 2026 after selling out during the quarter.
  • VarCov Co sold 2,895 Spyre Therapeutics shares in Q3 2026, an estimated $257K.
  • VarCov Co first reported a position in Spyre Therapeutics in Q4 2025 and held it in 2 quarters.
  • VarCov Co's Spyre Therapeutics position peaked at $262K in Q4 2025.
  • 286 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q3 2026.

Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.